CIGA Healthcare

CIGA Healthcare is a British manufacturer of lateral flow assay diagnostic tests.[1] It is under contract to the British government for the supply of AbC-19 rapid antibody tests,[2] a test for the presence of IgG antibody against the SARS-CoV-2 spike protein,[3] as part of the UK Rapid Test Consortium program.[4]

Distribution

CIGA Healthcare will be responsible for assembly and distribution of the AbC-19 rapid antibody tests, and has also been awarded distribution to the US after recent FDA approval.[5]

References

  1. ↑ "Abingdon Health announces its latest expansion and additional manufacturing capacity". Lifescience Industry News. 2020-06-18. Retrieved 2020-11-12.
  2. ↑ "Government invests in UK-developed antibody tests from UK Rapid Test Consortium". GOV.UK. Retrieved 2020-11-12.
  3. ↑ Gill, Dipender; Ponsford, Mark J. (2020-11-11). "Testing for antibodies to SARS-CoV-2". BMJ. 371. doi:10.1136/bmj.m4288. ISSN 1756-1833.
  4. ↑ Symon, Ken (2020-10-19). "Medical diagnostics company signs deal on delivery of Covid-19 tests". businessInsider. Retrieved 2020-11-12.
  5. ↑ "Yorkshire developed Covid-19 test approved for use in North America | TheBusinessDesk.com". Yorkshire. 2020-11-17. Retrieved 2021-04-13.
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.